An Interprofessional Approach to Diabetes Management



Similar documents
Diabetes Complications

Population Health Management Program

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Understanding diabetes Do the recent trials help?

Diabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes.

Healthy Living with Diabetes. Diabetes Disease Management Program

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

Type 1 Diabetes ( Juvenile Diabetes)

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care

DIABETES DISEASE MANAGEMENT PROGRAM DESCRIPTION FY11 FY12

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Baskets of Care Diabetes Subcommittee

Diabetes. C:\Documents and Settings\wiscs\Local Settings\Temp\Diabetes May02revised.doc Page 1 of 12

Value and Outcome Measurement in Health Care Delivery

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Facts about Diabetes in Massachusetts

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

The Economic Impact and Cost-Effectiveness of Glucose Monitoring

British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

The New Complex Patient. of Diabetes Clinical Programming

Provider Manual. Section Case Management and Disease Management

Renal Disease in Type 2 Diabetes Mellitus

Causes, incidence, and risk factors

An Integrated, Holistic Approach to Care Management Blue Care Connection

PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison

1. POSITION TITLE: CERTIFIED DIABETES EDUCATOR CLINICAL DIETITIAN Coordinator, Diabetes Self-Management Education Program

Presented by Jacque Corey, RN, CNS, CDE Kirsten Gram, RD, LD, CDE Sue McGrath, RN, CDE

Gayle Curto, RN, BSN, CDE Clinical Coordinator

Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene

Connecticut Diabetes Statistics

DR. Trinh Thi Kim Hue

DIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs

An Overview and Guide to Healthy Living with Type 2 Diabetes

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

4. Does your PCT provide structured education programmes for people with type 2 diabetes?

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact

Diabetes: The Numbers

Type 2 diabetes Definition

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat?

D I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E. Blindness Heart Disease Strokes Kidney Failure Amputation

2013 ACO Quality Measures

The Burden Of Diabetes And The Promise Of Biomedical Research

The UnitedHealthcare Diabetes Health Plan Better information. Better decisions. Better results. Agenda

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

DIABETES YOUR GUIDE TO

DIABETES MELLITUS GUIDELINES

Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge

How To Plan Healthy People 2020

Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)

Maryland s Partnership with Medicaid and DSME

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

Listen to your heart: Good Cardiovascular Health for Life

Type 2 Diabetes workshop notes

Diabetic Nephropathy

An Overview of Medicare Covered Diabetes Supplies and Services

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Beacon User Stories Version 1.0

CASE A1 Hypoglycemia in an Elderly T2DM Patient with Heart Failure

Guidelines for the management of hypertension in patients with diabetes mellitus

Scottish Diabetes Survey Scottish Diabetes Survey Monitoring Group

Clinician Guide: Bridges to Excellence Diabetes Care Recognition Program

HSAG: The QIN-QIO for Arizona, California, Florida, Ohio, and the U.S. Virgin Islands

Welcome to the Emory Diabetes Education Training Academy!

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs

Like John Fogerty said in one of his hit songs, I see a bad moon arising, How to Decrease Your Health Care Costs for Employees with Diabetes

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Management of Diabetes in the Elderly. Sylvia Shamanna Internal Medicine (R1)

Markham Stouffville Hospital

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

VCH PHCTF EVALUATION CORE INDICATORS, DATA COLLECTION PROCESSES, TOOLS & TARGETS

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

Diabetes and Heart Disease

HealthCare Partners of Nevada. Heart Failure

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks

Interactive Voice Response Technology To Prevent Type 2 Diabetes in Cardiac Population

Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins

Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease

Diabetes and Hypertension Care For Adults in Primary Care Settings

Transcription:

Disclosures An Interprofessional Approach to Diabetes Management Principal in DiabetesReframed, LLC. Inventor of U.S. Provisional Patent Application No. 61/585,483 METHODS OF USING A DIABETES CROSS- DISCIPLINARY INDEX TO STAGE DIABETES IN A PATIENT Andrew S. Pumerantz, DO, FACP Assistant Provost for Strategic Initiatives Executive Director, WDI Associate Professor of Internal Medicine Chief, Division of Infectious Disease WesternU/COMP Learning Objectives 1. Outline the challenges faced by interprofessional teams in successfully delivering high-value integrated and coordinated fullcycle care to patients with diabetes. 2. Relate the complex interplay between abnormal glucose and lipid metabolism and inflammatory dysregulation to the complications of poorly controlled diabetes. 3. Justify the restructuring of health care delivery systems to assure closer collaboration between medical and dental clinical teams to better diagnose and manage patients with diabetes and periodontitis. 4. Justify organizing interprofessional diabetes management teams around a core collaborative therapeutic alliance between the patient, a clinical pharmacist, and a PA care coordinator. 5. Justify designing personalized full-cycle diabetes care plans based on a patient's specific disease severity and complexity index profile. 1

Complex interplay between abnormal glucose and lipid metabolism and inflammatory dysregulation Multiple organ system complications 2x risk of premature death US spent $201 billion in 2011 Major cost driver: lack of control of the ABCs (HbA1c, BP, and LDL-C) HbA1c 7% risk for hospitalizations and prolonged stay http://www.idf.org/diabetesatlas/5e/healthcare expenditures Care New-patient goals: 1. Detect presence of complications 2. Formulate management plan 3. Provide basis for continuing care cdc.gov ADA Clinical Practice Guidelines. Diabetes Care 2012; 35 (Suppl 1) 2

Plan Management should be formulated as a collaborative therapeutic alliance between patient, family, and health care team Implementation requires understanding and agreement between patient and care providers, and that goals and treatment plan are reasonable Comprehensive foot examination ADA Clinical Practice Guidelines. Diabetes Care 2012; 35 (Suppl 1) ADA Clinical Practice Guidelines. Diabetes Care 2012; 35 (Suppl 1) Adults aged 18 years with Diagnosed Diabetes Receiving Preventive Care Practices, United States, 2010 (Age-Adjusted) http://www.cdc.gov/diabetes/statistics/preventive/fallpractices.htm Dartmouth Hitchcock Diabetes Program 3

my.clevelandclinic.org/documents/outcomes/2010/outcomes medicine 2010.pdf Severe periodontitis and diabetes HbA1c 9% risk for severe periodontitis Periodontitis increases insulin resistance 2x incidence of macroalbuminuria 3x increased incidence of ESRD 3x higher risk of cardiorenal mortality 4

Two-way relationship Periodontitis prevalence at WDI A total of 22 pilot patients (May 2011-April 2012) were evaluable [mean HbA1c 9.0% (range, 5.3%-17.4%)] 17 (73%) had periodontitis 5 (23%) were classified as severe * [mean HbA1c 10.3% (range, 6.6%-17.4%)] 5 (23%) as moderate 5 (23%) had no periodontitis [mean HbA1c 8.7% (range, 7.2%-11.5%)] *severe periodontitis was defined as clinical attachment loss (CAL) of 5 mm (bone level >6 mm) Challenges to delivering high-value diabetes care Complex interplay of multiple organ systems Incomplete evaluations (~50%) 21 st -century medical science delivered in 19 th -century organizational structure Patient compliance (engagement) ~30% Providers from disparate disciplines and no common language Medical and dental teams rarely collaborative Clinically integrated team or collection of fragmented services? Need for measurement of full-cycle outcomes and costs No composite disease-severity staging index No adequate disease registry IT platform EHR Reframing 5

(DXDI ) RD: Nutritional assessment Endocrinology: Screen for HTN, dyslipidemia, nephropathy, depression Patient Clinical Pharmacist PA Care Coordinator (CoreCTA*) Optometry: Dilated & Comprehensive Eye Exam with Retinal Scan Physical Therapy: Screen for neuropathy, PAD, & functionality Initial Assessment Dental: Comprehensive Periodontal 2 D echo: Assessment Screen for structural heart disease *Core Collaborative Therapeutic Alliance PA Care Coordinator: Functions as a member of the CoreCTA to develop a care management plan based on the patient s DXDI profile and ensure the patient understands its implications, is committed to the education and other follow-up activities involved in the total care cycle. Coordinates patient navigation throughout care cycle including healthy eating habits, physical activity, medication adherence, self-management education classes, referrals, glucose selfmonitoring, and goals for HbA1c, blood pressure, and cholesterol levels. Identifies obstacles to implementing care plan Coordinates care plan with patient s PCP and provides direct patient care within the context of the integrated practice unit care team. PA Care Coordinator: Staffs and co-manages patients with WDI Clinical Pharmacist in the Diabetes Medication Management and Insulin Titration Clinic. Reviews patients records for efficient drug therapy, drug-drug interactions, adverse reactions, contraindications, allergies, and sensitivities. Follows through with resolving medication therapy issues. Enters into, and follows, data through WDI registry/ehr 6

A morbidly-obese 39-year-old man (BMI 37) is referred by his PCP with new diagnosis of diabetes. PMHx hypertension. Takes hydrochlorothiazide. Smokes one pack/day. Family history of type 2 diabetes and cardiovascular disease in his mother and older brother. HbA1c 8.9% BP 140/90 LDL-C 120 mg/dl Retina: dot-blot hemorrhages/cotton wool spots Oral cavity: Severe periodontitis Feet: + sensory neuropathy Functionality: modified-independent egfr: 95 ml/min/1.73 m 2 urinary albumin-creatinine ratio (ACR): 20 mg/g 2-D Echo: MAC, LV hypertrophy and LVEF 55% (DXDI ) 7

Metabolic & Bariatric Surgery MNT & DSME Center for Fitness and Function Endocrine & Glycemic Management Clinics CoreCTA Cardiology consult in Heart and Vascular Center Eye Care Center Dental Center Measuring Outcomes Survival Degree of health Time to health and functionality Experience and disutility of care Sustainability of health over time Long term consequences of therapy Mortality Severity of end-organ disease complications (DXDI staging) ) Functional level and degree of independency Level of satisfaction with health status Time to reaching ABC target goals Time to reaching highest functional level) Length of hospital stay, if necessary Treatment-related discomfort, complications, adverse effects, diagnostic errors, treatment errors Level of satisfaction of care Maintain functional level and ability to live independently Maintain glycemic control Maintain blood pressure <130/80 De novo end-organ disease complications Recovered end-organ disease complications Care-induced illness (e.g., hypoglycemic episodes) (DXDI ) WDI Cloud Dental Center Center for Kidney Disease Endocrine Clinic and Hypertension Diabetes Medication Management and Insulin Titration Clinic Heart and Vascular Center Eye Care Center Center for Fitness and Function Clinical Research Unit MNT & DSME ID Clinic Amputation Prevention Center 8

Summary 1. Organize integrated, interprofessional teams around CoreCTA. 2. PA Care Coordinator is a linchpin for the WDI integrated practice unit. 3. Stratify patients based on a composite disease-severity index. 4. Personalize care plans aligned with patient goals and based on their index profile. 5. Engage all stakeholders (patient, caregivers, providers, and payers). 6. Build and maintain an index-based disease registry IT platform. 7. Measure outcomes and cost across care cycle to keep improving. 9